NCT07037979

Brief Summary

To evaluate the correlation of Sarcopenia Parameters and Peripheral Artery Disease with chronic limb threatening ischaemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 5, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 26, 2025

Completed
Last Updated

June 26, 2025

Status Verified

June 1, 2025

Enrollment Period

2 years

First QC Date

June 5, 2025

Last Update Submit

June 24, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • psoas muscle area (PMA) [measured by computed tomography (CT)]

    psoas muscle area (PMA) (square centimeters) was regarded as a kind of typical sarcopenia parameters, measured by computed tomography (CT) at the L3 vertebral level

    2023.1.1~2024.12.31

  • total abdominal muscle area (TAMA) measured by computed tomography (CT)

    total abdominal muscle area (TAMA) (square centimeters) was regarded as a kind of typical sarcopenia parameters, measured by computed tomography (CT) at the L3 vertebral level

    2023.1.1~2024.12.31

Study Arms (1)

patiets with peripheral artery disease

Other: Not applicable- observational study

Interventions

non-applicable

patiets with peripheral artery disease

Eligibility Criteria

Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients of Peripheral Artery Disease

You may qualify if:

  • Patients of Peripheral Artery Disease, including intermittent claudication and Chronic Limb Threatening Ischemia;
  • Patients with Rutherford grade 2-6 between Jan.1 2023 and Dec.31 2024;
  • Patients at age 18-80;
  • Patients underwent an in-hospital routine enhanced whole abdomen to lower extremities CT scan;
  • Patients able to complete the clinical follow-up for 3 months.

You may not qualify if:

  • Poor CT quality or incomplete images;
  • Incomplete clinical data;
  • In-hospital mortality during Jan.1 2023 and Dec.31 2024.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Huadong Hospital, Fudan University

Shanghai, 200040, China

Location

MeSH Terms

Conditions

SarcopeniaPeripheral Arterial DiseaseChronic Limb-Threatening Ischemia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsAtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesIschemia

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Hospital director

Study Record Dates

First Submitted

June 5, 2025

First Posted

June 26, 2025

Study Start

January 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

June 26, 2025

Record last verified: 2025-06

Locations